Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis

Hematological Oncology, EarlyView.

Source: Hematological Oncology - June 8, 2018 Category: Hematology Authors: PanagiotisTsirigotis , TheodorosVassilakopoulos , IoannisBatsis , ZoiBousiou , KonstantinosGkirkas , IoannaSakellari , PanayotisKaloyannidis , ParaskeviRoussou , Gerassimos A.Pangalis , MariaMoschogiannis , GeorgeVassilopoulos , Pan Source Type: research